J.P. Morgan favors European platforms on growth, sees UK backdrop as drag

J.P. Morgan resumed European investment-platform and exchange coverage with Overweight ratings on TP ICAP (461p target), FinecoBank (€29), Banca Mediolanum (€28), Nordnet (SEK401), LSEG (10,600p) and Deutsche Boerse (€345), all with December 2027 targets. The bank expects accelerating growth and potential consensus upgrades for selected continental European platforms, while flagging FinecoBank and Mediolanum ahead of Nov. 5 and Nov. 10 Q3 results. It downgraded St. James’s Place and Aberdeen to Neutral amid UK flow risks from higher rates and possible Autumn Budget tax increases; its £0.9B Q3 net-flow forecast for St. James’s Place is about 20% below consensus.

Analysis

The actionable split is rate sensitivity rather than a broad European financials call. UK advised-wealth models (STJ, ABDN) face a double hit if fiscal tightening depresses household saving and gilt yields remain restrictive: weaker gross flows reduce fee revenue while fixed adviser, service and remediation costs create negative operating leverage. By contrast, FBK and BMED retain more favorable retail-savings economics, where deposit repricing and structurally underpenetrated managed-money adoption can support earnings even if European risk assets consolidate.

LSEG and Deutsche Boerse (DB1) are higher-quality ways to express durable financial-market infrastructure demand, but their near-term upside depends on estimates rather than the AI narrative. AI is more likely to raise data-product differentiation and workflow switching costs for incumbents than commoditize their regulated, proprietary datasets; the relevant falsifier is sustained deceleration in recurring data/analytics growth or evidence of AI-native tools driving client budget displacement. TCAP offers a more cyclical upside expression: improving market volumes and asset-class electronification can lift revenue faster than costs over 6-18 months, but it has more sensitivity to a volatility/volume downturn.

The consensus risk is treating a broker coverage reset and long-dated price targets as an immediate catalyst. The cleanest 1-3 month event path is the UK wealth-management reporting cycle, where net-flow misses would force FY estimates lower; Italian platform upside requires verified net new money and NII resilience rather than simply stable rates. Euronext (ENX) looks relatively less compelling as a standalone long because much of the growth/valuation rerating case appears priced, making it a useful funding leg against DB1 or LSEG if exchange volumes stay healthy.

Key Decisions for Investors

• Initiate a 3-6 month pair: long LSEG / short ENX, sized beta-neutral. LSEG has a more defensible recurring-data earnings mix, while ENX is more exposed to a valuation reset if cash-equity and listing activity disappoint; review if LSEG recurring revenue growth decelerates materially or the relative spread widens 10-12% without estimate upgrades.
• Buy TCAP on weakness ahead of the next results cycle, targeting a 6-12 month holding period. The thesis requires accelerating revenue growth and positive operating leverage; use a 12-15% risk limit, with a failure signal being lower market-activity guidance or no evidence of margin expansion.
• Maintain an underweight or tactical short STJ versus QLT through the UK reporting window. The relative trade isolates UK advised-wealth flow and cost-pressure risk while retaining some domestic financials exposure; cover on net flows above consensus and a clear improvement in retention/cost guidance.
• Add FBK and BMED only after quarterly disclosures confirm positive net inflows and stable NII expectations. A 6-18 month long basket is attractive if those metrics hold, but do not chase a rate-cut rally: faster-than-expected ECB easing or deposit-beta deterioration would compress the earnings support underpinning the thesis.